Cargando…

A Practice Based Behavioral Health Management Registry (BHMR): Implementation, Structure and Content

Previous commentaries in the Formulary Evaluation section of INNOVATIONS in Pharmacy have pointed to the difficulties of establishing the credibility of trial-based and modeled claims for therapy interventions. Claims for interventions in behavioral health are no exception. A recent report by The Ke...

Descripción completa

Detalles Bibliográficos
Autor principal:	Langley, Paul C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of Minnesota Libraries Publishing 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592857/ https://www.ncbi.nlm.nih.gov/pubmed/34007541 http://dx.doi.org/10.24926/iip.v10i2.1782

Ejemplares similares

A Practice Based Chronic Pain Management Registry (CPMR): Structure and Content of Proposed Patient and Patient/Provider Platforms
por: Langley, Paul C
Publicado: (2019)

Meeting Physician Compliance Recommendations in the Management of Opioids in Chronic Pain: The Chronic Pain Management Registry (CPMR)
por: Langley, Paul C
Publicado: (2019)

Establishing Credibility for Medical Marijuana: The Proposed Prometheus Dispensary Registry for Botanical Cannabis
por: Langley, Paul C
Publicado: (2019)

Outcomes, Registries and Medical Marijuana: Towards Establishing Dispensary Monitoring and Reporting Standards
por: Langley, Paul C
Publicado: (2018)

Tracking and Reporting Outcomes in Medical Marijuana: Establishing Condition Specific State Level Registries
por: Langley, Paul C
Publicado: (2019)

Establishing Practice Risk Management and Outcomes Claims for Medical Marijuana Dispensaries: Questions Legislators Should Ask
por: Langley, Paul C
Publicado: (2019)

Considerations for the development and implementation of electronic immunization registries in Africa
por: Namageyo-Funa, Apophia, et al.
Publicado: (2018)

Using organization theory to position middle-level managers as agents of evidence-based practice implementation
por: Birken, Sarah A., et al.
Publicado: (2021)

CVS Health and the Imaginary Worlds of the Institute for Clinical and Economic Review (ICER)
por: Langley, Paul C
Publicado: (2018)

Suspension of the National Registry of Evidence-Based Programs and Practices: the importance of adhering to the evidence
por: Green-Hennessy, Sharon
Publicado: (2018)

The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds in Health Technology Assessment
por: Langley, Paul C
Publicado: (2020)

Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes
por: Wong, Michael K, et al.
Publicado: (2014)

Peter Rabbit is a Badger in Disguise: Deconstructing the Belief System of the Institute for Clinical and Economic Review in Health Technology Assessment
por: Langley, Paul C
Publicado: (2021)

Formulary Submissions: Value Claims, Protocols and Outcomes Based Contracting in Rare Disease
por: Langley, Paul C
Publicado: (2022)

Blockchains, Formulary Evaluations and Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2018)

From Implementation Towards Change Management: A Plea for a Multi-stakeholder View on Innovation Implementation: Comment on "What Managers Find Important for Implementation of Innovations in the Healthcare Sector – Practice Through Six Management Perspectives"
por: Martens, Monika, et al.
Publicado: (2022)

If You Build it Will They Come? Patients, Providers and Blockchains in Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2018)

Blockchains, Property Rights and Health Technology Assessment in the Pharmaceutical and Device (s) Industries
por: Langley, Paul C, et al.
Publicado: (2018)

Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry
por: Efficace, Fabio, et al.
Publicado: (2014)

After The QALY: Training for a New Start Paradigm in Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2023)

Leveraging a Partnership to Disseminate and Implement What Works in Family Planning and Reproductive Health: The Implementing Best Practices (IBP) Initiative
por: Thatte, Nandita, et al.
Publicado: (2019)

Beyond Organisational Borders: The Soft Power of Innovation in the Health Sector: Comment on "What Managers Find Important for Implementation of Innovations in the Healthcare Sector – Practice Through Six Management Perspectives"
por: Costa, Cátia Miriam
Publicado: (2022)

NICE shared decision making guidelines and mental health: challenges for research, practice and implementation
por: Zisman-Ilani, Yaara, et al.
Publicado: (2021)

Implementing Keytruda/Pembrolizumab Testing in Clinical Practice
por: Ratner, Dmitry, et al.
Publicado: (2018)

The Need And Benefit of Implementing Telemedicine in Clinical Practice
por: Burguera, Bartolome, et al.
Publicado: (2020)

ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
por: Langley, Paul C
Publicado: (2019)

Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular Therapies
por: Langley, Paul C
Publicado: (2019)

Another Rush to Judgment: The Imaginary Worlds of ICER and Recommendations in Duchenne Muscular Dystrophy
por: Langley, Paul C
Publicado: (2019)

The Imaginary Worlds of Cure Proportion Modeling: Survivorship and Reference Case Pricing of Transformative Therapies
por: Langley, Paul C
Publicado: (2019)

Value Assessment in Cystic Fibrosis: ICER’s Rejection of the Axioms of Fundamental Measurement
por: Langley, Paul C
Publicado: (2020)

More Unnecessary Imaginary Worlds – Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease
por: Langley, Paul C
Publicado: (2020)

Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission Guidelines
por: Langley, Paul C
Publicado: (2020)

To Dream the Impossible Dream: The Commitment by the Institute for Clinical and Economic Review to Rewrite the Axioms of Fundamental Measurement for Hemophilia A and Bladder Cancer Value Claims
por: Langley, Paul C
Publicado: (2020)

The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER)
por: Langley, Paul C
Publicado: (2020)

The Great I-QALY Disaster
por: Langley, Paul C.
Publicado: (2020)

Let a Thousand Models Bloom: ICER Analytics Opens the Floodgates to Cloud Pseudoscience
por: Langley, Paul C
Publicado: (2021)

Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021)

Nonsense on Stilts – Part 1: The ICER 2020-2023 Value Assessment Framework for Constructing Imaginary Worlds
por: Langley, Paul C
Publicado: (2020)

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
por: Langley, Paul C
Publicado: (2020)

More Unnecessary Imaginary Worlds – Part 2: The ICER Evidence Report on Modeling Oral Semaglutide for Type 2 Diabetes
por: Langley, Paul C
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hnt738mu92cd973k6nt8ts6r3d